Two Sigma Securities’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$34.1K Buy
34,788
+16,892
+94% +$15.4K ﹤0.01% 1429
2026
Q1
$18.1K Sell
17,896
-1,753
-9% -$1.7K ﹤0.01% 1385
2025
Q4
$16.5K Buy
+19,649
New +$19.7K ﹤0.01% 1206
2025
Q3
Sell
-21,835
Closed -$28.7K 1904
2025
Q2
$28.7K Buy
+21,835
New +$24.9K ﹤0.01% 1159
2025
Q1
Sell
-11,704
Closed -$15.1K 2087
2024
Q4
$15.1K Buy
+11,704
New +$13.3K ﹤0.01% 1367
2021
Q4
Sell
-17,944
Closed -$108K 1975
2021
Q3
$108K Buy
+17,944
New +$149K ﹤0.01% 1300

Other funds holding RNXT

Two Sigma Securities's RNXT Position: Q2 2026 in Review

Two Sigma Securities increased its RenovoRx (RNXT) stake by 94% in Q2 2026, buying an estimated $15.4K and bringing the position to 34,788 shares worth $34.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1429.

Two Sigma Securities first reported a position in RNXT in Q3 2021 and has held it in 6 quarters since. The position peaked at $108K in Q3 2021. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Two Sigma Securities held 34,788 shares of RenovoRx worth $34.1K as of Q2 2026.
  • Two Sigma Securities bought 16,892 RenovoRx shares in Q2 2026, an estimated $15.4K.
  • RenovoRx made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1429 holding.
  • Two Sigma Securities first reported a position in RenovoRx in Q3 2021 and has held it in 6 quarters since.
  • Two Sigma Securities's RenovoRx position peaked at $108K in Q3 2021.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.